Intrastriatal injections of KN-93 ameliorates levodopa-induced dyskinesia in a rat model of Parkinson’s disease

References

• DevineMJGwinnKSingletonAHardyJParkinson’s disease and α-synuclein expressionMov Disord201126122160216821887711
   PubMed Web of Science ®Google Scholar
• IravaniMMJennerPMechanisms underlying the onset and expression of levodopa-induced dyskinesia and their pharmacological manipulationJ Neural Transm2011118121661169021881839
   PubMed Web of Science ®Google Scholar
• CartaMBezardEContribution of pre-synaptic mechanisms to L-DOPA-induced dyskinesiaNeuroscience201119824525121840375
   PubMed Web of Science ®Google Scholar
• MelaFMartiMBidoSCenciMAMorariMIn vivo evidence for a differential contribution of striatal and nigral D1 and D2 receptors to L-DOPA induced dyskinesia and the accompanying surge of nigral amino acid levelsNeurobiol Dis201245157358222001605
   PubMed Web of Science ®Google Scholar
• KobyleckiCHillMPCrossmanARRavenscroftPSynergistic antidyskinetic effects of topiramate and amantadine in animal models of Parkinson’s diseaseMov Disord201126132354236321953539
   PubMed Web of Science ®Google Scholar
• SantiniESgambato-FaureVLiQDistinct changes in cAMP and extracellular signal-regulated protein kinase signalling in L-DOPA-induced dyskinesiaPLoS ONE201058e1232220808799
   PubMed Web of Science ®Google Scholar
• BaMKongMYuGSunXLiuZWangXGluR1 phosphorylation and persistent expression of levodopa-induced motor response alterations in the Hemi-Parkinsonian ratNeurochem Res20113661135114421461922
   PubMed Web of Science ®Google Scholar
• MahmoudiSSamadiPGilbertFNur77 mRNA levels and L-Dopa-induced dyskinesias in MPTP monkeys treated with docosahexaenoic acidNeurobiol Dis200936121322219635563
   PubMed Web of Science ®Google Scholar
• Sgambato-FaureVBuggiaVGilbertFLévesqueDBenabidALBergerFCoordinated and spatial upregulation of arc in striatonigral neurons correlates with L-dopa-induced behavioral sensitization in dyskinetic ratsJ Neuropathol Exp Neurol2005641193694716254488
   PubMed Web of Science ®Google Scholar
• DarmopilSMartínABDe DiegoIRAresSMoratallaRGenetic inactivation of dopamine D1 but not D2 receptors inhibits L-DOPA-induced dyskinesia and histone activationBiol Psychiatry200966660361319520364
   PubMed Web of Science ®Google Scholar
• PaxinosGWatsonCThe Rat Brain in Stereotaxic CoordinatesSydneyAcademic Press2007
   Google Scholar
• MorgeseMGCassanoTCuomoVGiuffridaAAnti-dyskinetic effects of cannabinoids in a rat model of Parkinson’s disease: role of CB(1) and TRPV1 receptorsExp Neurol2007208111011917900568
   PubMed Web of Science ®Google Scholar
• AlcacerCSantiniEValjentEGavenFGiraultJAHervéDGα(olf) mutation allows parsing the role of cAMP-dependent and extracellular signal-regulated kinase-dependent signaling in L-3,4-dihydroxyphenylalanine-induced dyskinesiaJ Neurosci201232175900591022539851
   PubMed Web of Science ®Google Scholar
• AbuirmeilehAHarkavyiARampersaudNExendin-4 treatment enhances L-DOPA evoked release of striatal dopamine and decreases dyskinetic movements in the 6-hydoxydopamine lesioned ratJ Pharm Pharmacol201264563764322471359
   PubMed Web of Science ®Google Scholar
• MaranisSStamatisDTsironisCKonitsiotisSInvestigation of the antidyskinetic site of action of metabotropic and ionotropic glutamate receptor antagonists. Intracerebral infusions in 6-hydroxydopamine-lesioned rats with levodopa-induced dyskinesiaEur J Pharmacol20126831–3717722410193
   PubMed Web of Science ®Google Scholar
• CheshirePAWilliamsDRSerotonergic involvement in levodopa-induced dyskinesias in Parkinson’s diseaseJ Clin Neurosci201219334334822249009
   PubMed Web of Science ®Google Scholar
• SantiniEValjentEUsielloACritical involvement of cAMP/DARPP-32 and extracellular signal-regulated protein kinase signaling in L-DOPA-induced dyskinesiaJ Neurosci200727266995700517596448
   PubMed Web of Science ®Google Scholar
• QuintanaASgambato-FaureVSavastaMEffects of L-DOPA and STN-HFS dyskinesiogenic treatments on NR2B regulation in basal ganglia in the rat model of Parkinson’s diseaseNeurobiol Dis201248337939022759925
   PubMed Web of Science ®Google Scholar
• IderbergHFrancardoVPioliEYAnimal models of L-DOPA-induced dyskinesia: an update on the current optionsNeuroscience2012211132722465440
   PubMed Web of Science ®Google Scholar
• KongMBaMSongLLiuZComparative effects of acute or chronic administration of levodopa to 6-OHDA-lesioned rats on the expression and phosphorylation of N-methyl-D-aspartate receptor NR1 subunits in the striatumNeurochem Res20093481513152119283475
   PubMed Web of Science ®Google Scholar
• TakumaKTanakaTTakahashiTNeuronal nitric oxide synthase inhibition attenuates the development of L-DOPA-induced dyskinesia in hemi-Parkinsonian ratsEur J Pharmacol20126831–316617322449381
   PubMed Web of Science ®Google Scholar
• MaranisSStamatisDTsironisCKonitsiotisSInvestigation of the antidyskinetic site of action of metabotropic and ionotropic glutamate receptor antagonists. Intracerebral infusions in 6-hydroxydopamine-lesioned rats with levodopa-induced dyskinesiaEur J Pharmacol20126831–3717722410193
   PubMed Web of Science ®Google Scholar
• LeesAFahnSEggertKMPerampanel, an AMPA antagonist, found to have no benefit in reducing “off” time in Parkinson’s diseaseMov Disord201227228428822161845
   PubMed Web of Science ®Google Scholar
• KobyleckiCCenciMACrossmanARRavenscroftPCalcium-permeable AMPA receptors are involved in the induction and expression of l-DOPA-induced dyskinesia in Parkinson’s diseaseJ Neurochem2010114249951120456008
   PubMed Web of Science ®Google Scholar
• OuattaraBHoyerDGrégoireLChanges of AMPA receptors in MPTP monkeys with levodopa-induced dyskinesiasNeuroscience201016741160116720303391
   PubMed Web of Science ®Google Scholar
• SilverdaleMAKobyleckiCHallettPJSynaptic recruitment of AMPA glutamate receptor subunits in levodopa-induced dyskinesia in the MPTP-lesioned nonhuman primateSynapse201064217718019852073
   PubMed Web of Science ®Google Scholar
• TamimMKSamadiPMorissetteMEffect of non-dopaminergic drug treatment on Levodopa induced dyskinesias in MPTP monkeys: common implication of striatal neuropeptidesNeuropharmacology201058128629619576910
   PubMed Web of Science ®Google Scholar
• WestinJEVercammenLStromeEMKonradiCCenciMASpatiotemporal pattern of striatal ERK1/2 phosphorylation in a rat model of L-DOPA-induced dyskinesia and the role of dopamine D1 receptorsBiol Psychiatry200762780081017662258
   PubMed Web of Science ®Google Scholar